Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosusJing He, Zhanguo Li, Nan Shen et al.|Nature Medicine|2016Cited by 570
Functional rare and low frequency variants in BLK and BANK1 contribute to human lupusSimon Jiang, Carola G. Vinuesa, Vicki Athanasopoulos et al.|Nature Communications|2019Cited by 122
Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5+ dermatomyositis with therapeutic implicationsYan Ye, Xiaoming Zhang, Zechuan Chen et al.|Nature Communications|2022Cited by 112
SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expressionGuojun Hou, Nan Shen|Nature Communications|2021Cited by 69
Identification of Renal Long Non-coding RNA RP11-2B6.2 as a Positive Regulator of Type I Interferon Signaling Pathway in Lupus NephritisZhuojun Liao, Nan Shen|Frontiers in Immunology|2019Cited by 65